Clicky

Xeris Pharmaceuticals, Inc.(XERS)

Description: Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.


Keywords: Natural Sciences Pharmaceutical Pharmacy Health Sciences Pharmaceutical Sciences Pharmaceutics Pharmaceutical Formulation

Home Page: www.xerispharma.com

XERS Technical Analysis

180 North LaSalle Street
Chicago, IL 60601
United States
Phone: 844 445 5704


Officers

Name Title
Mr. Paul R. Edick Chairman & CEO
Mr. John P. Shannon Pres & COO
Ms. Beth P. Hecht J.D. Chief Legal Officer & Corp. Sec.
Dr. Steven J. Prestrelski MBA, Ph.D. Co-Founder & Chief Scientific Officer
Mr. Steven M. Pieper Chief Financial Officer
Ms. Allison Wey Sr. VP of Investor Relations & Corp. Communications
Dr. Kenneth E. Johnson Pharm. D., Pharm.D. Sr. VP of Global Devel. & Medical Affairs
Mr. Kevin McCulloch Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.4095
Price-to-Sales TTM: 1.8493
IPO Date: 2018-06-21
Fiscal Year End: December
Full Time Employees: 294
Back to stocks